MLH1 and cancer: This functional link between MLH1 and XIAP suggests that XIAP status may influence the effectiveness of MLH1-dependent responses to chemotherapy and that an inhibition of XIAP, in particular in MLH1-proficient cancers, may improve the CR of EOC patients to chemotherapy.